Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Exp Eye Res ; 85(4): 462-72, 2007 Oct.
Article in English | MEDLINE | ID: mdl-17765224

ABSTRACT

Reactive oxygen species (ROS) generated during inflammation are believed to play critical roles in various ocular diseases. However, the underlying mechanisms remain poorly understood. We investigated if pro-inflammatory cytokines, tumor necrosis factor (TNF)-alpha, interleukin-1 beta (IL-1 beta), and interferon-gamma (IFN-gamma), induce ROS in human retinal pigment epithelial (RPE) cells. TNF-alpha, IL-1 beta and IFN-gamma increased both intracellular and extracellular ROS production in a time- and dose-dependent manner. Thenoyltrifluoroacetone (TTFA), an inhibitor of mitochondrial respiratory chain, blocked TNF-alpha- and IFN-gamma-, but not IL-1 beta-induced ROS, whereas other two mitochondrial respiratory chain inhibitors, rotenone and antimycin A, had no effect. NADPH oxidase inhibitor (diphenylene iodinium) abolished the ROS production induced by IL-1 beta or IFN-gamma, but not by TNF-alpha, whereas 6-aminonicotinamide (6AN), an inhibitor of the hexose monophosphate shunt (HMS), had no significant effects on the ROS induced by all three cytokines. ROS scavengers, pyrrolidinedithiocarbamate (PDTC) and N-acetyl-cysteine (NAC), reduced the levels of ROS induced by TNF-alpha, IL-1 beta and IFN-gamma (P<0.05). Collectively, these results demonstrate that TNF-alpha, IL-1 beta and IFN-gamma increase mitochondrial- and NADPH oxidase-generated ROS in human RPE cells.


Subject(s)
Cytokines/pharmacology , Inflammation Mediators/pharmacology , Pigment Epithelium of Eye/drug effects , Reactive Oxygen Species/metabolism , Cells, Cultured , Dose-Response Relationship, Drug , Electron Transport/drug effects , Electron Transport/physiology , Enzyme Inhibitors/pharmacology , Humans , Hydrogen Peroxide/metabolism , Interferon-gamma/pharmacology , Interleukin-1beta/pharmacology , Mitochondria/physiology , NADPH Oxidases/antagonists & inhibitors , NADPH Oxidases/metabolism , Onium Compounds/pharmacology , Pigment Epithelium of Eye/cytology , Pigment Epithelium of Eye/metabolism , Recombinant Proteins/pharmacology , Tumor Necrosis Factor-alpha/pharmacology
2.
J Appl Toxicol ; 26(2): 126-31, 2006.
Article in English | MEDLINE | ID: mdl-16252256

ABSTRACT

Airway instillation into rats of 2-chloroethyl ethyl sulfide (CEES), the half molecule of sulfur mustard compound, results in acute lung injury, as measured by the leak of plasma albumin into the lung. Morphologically, early changes in the lung include alveolar hemorrhage and fibrin deposition and the influx of neutrophils. Following lung contact with CEES, progressive accumulation of collagen occurred in the lung, followed by parenchymal collapse. The co-instillation with CEES of liposomes containing pegylated (PEG)-catalase (CAT), PEG-superoxide dismutase (SOD), or the combination, greatly attenuated the development of lung injury. Likewise, the co-instillation of liposomes containing the reducing agents, N-acetylcysteine (NAC), glutathione (GSH), or resveratrol (RES), significantly reduced acute lung injury. The combination of complement depletion and airway instillation of liposomes containing anti-oxidant compounds maximally attenuated CEES-induced lung injury by nearly 80%. Delayed airway instillation of anti-oxidant-containing liposomes (containing NAC or GSH, or the combination) significantly diminished lung injury even when instillation was delayed as long as 1 h after lung exposure to CEES. These data indicate that CEES-induced injury of rat lungs can be substantially diminished by the presence of reducing agents or anti-oxidant enzymes delivered via liposomes.


Subject(s)
Chemical Warfare Agents/poisoning , Lung Diseases/chemically induced , Lung Diseases/prevention & control , Mustard Gas/analogs & derivatives , Acute Disease , Animals , Antioxidants/administration & dosage , Antioxidants/therapeutic use , Catalase/administration & dosage , Catalase/therapeutic use , Complement System Proteins/physiology , Drug Delivery Systems , Enzyme Therapy , Enzymes/administration & dosage , Liposomes , Lung/pathology , Lung Diseases/pathology , Male , Mustard Gas/poisoning , Rats , Rats, Long-Evans , Reducing Agents/administration & dosage , Reducing Agents/therapeutic use , Superoxide Dismutase/administration & dosage , Superoxide Dismutase/therapeutic use
3.
J Appl Toxicol ; 22(4): 257-62, 2002.
Article in English | MEDLINE | ID: mdl-12210543

ABSTRACT

The chemical warfare agent analog, 2-chloroethyl ethyl sulfide, known as 'half-mustard gas' (HMG), is less toxic and less of an environmental hazard than the full molecule and has been shown to produce an acute lung injury in rats when instilled via intrapulmonary injection. This injury is characterized by massive, localized hemorrhage and edema into the alveolar compartment and can be quantitated by measuring extravasation of (125)I-bovine serum albumin into the extravascular compartment. Employing this rat model of HMG-induced lung injury, we observed significant attenuation of the pulmonary injury when experimental animals were complement or neutrophil depleted prior to HMG challenge. Significant protection also was provided by the use of antioxidants such as catalase, dimethyl sulfoxide, dimethyl thiourea, resveratrol and N-acetyl-L-cysteine (NAC). The last compound showed protection from lung injury as high as 70% and was still effective even when given up to 90 min after exposure of the lungs to HMG. These data suggest that acute lung injury caused by exposure to HMG may be related partially to complement mediated pathways and the generation by neutrophils of toxic oxygen species The data indicate that NAC is an effective antidote against HMG-induced acute lung injury in the rat.


Subject(s)
Antioxidants/therapeutic use , Mustard Gas/analogs & derivatives , Mustard Gas/toxicity , Respiratory Distress Syndrome/prevention & control , Animals , Antioxidants/administration & dosage , Complement System Proteins/deficiency , Complement System Proteins/drug effects , Disease Models, Animal , Dose-Response Relationship, Drug , Elapid Venoms/pharmacology , Injections, Intraperitoneal , Intubation, Intratracheal , Lung/drug effects , Lung/pathology , Male , Mustard Gas/administration & dosage , Neutropenia/immunology , Neutrophils/immunology , Rats , Rats, Long-Evans , Respiratory Distress Syndrome/chemically induced , Respiratory Distress Syndrome/pathology , Specific Pathogen-Free Organisms
SELECTION OF CITATIONS
SEARCH DETAIL
...